Ardelyx Newsroom

Piper Sandler Maintains Ardelyx(ARDX.US) With Hold Rating, Maintains Target Price $7

Futu NewsOct 23 20:31

Piper Sandler Maintains Ardelyx(ARDX.US) With Hold Rating, Maintains Target Price $7

Futu NewsOct 3 19:34

Piper Sandler Remains a Hold on Ardelyx (ARDX)

TipRanksOct 3 18:47

Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Ardelyx (ARDX)

TipRanksSep 4 17:08

Analysts' Opinions Are Mixed on These Healthcare Stocks: Blueprint Medicines (BPMC), Adaptimmune Therapeutics (ADAP) and Ardelyx (ARDX)

TipRanksAug 7 14:06

Ardelyx Analyst Ratings

BenzingaAug 6 01:48

HC Wainwright & Co. Maintains Buy on Ardelyx, Raises Price Target to $11

BenzingaAug 6 01:48

H.C. Wainwright Maintains Ardelyx(ARDX.US) With Buy Rating, Raises Target Price to $11

Futu NewsAug 5 18:31

Ardelyx: Strong Sales Growth and Strategic Expansion Drive Buy Rating

TipRanksAug 5 18:24

Ardelyx Analyst Ratings

BenzingaAug 2 21:07

Wedbush Reiterates Outperform on Ardelyx, Maintains $11 Price Target

BenzingaAug 2 21:07

A Quick Look at Today's Ratings for Ardelyx(ARDX.US), With a Forecast Between $7 to $12

Futu NewsAug 2 21:05

Ardelyx's Robust Drug Performance and Growth Potential Warrants a Buy Rating

TipRanksAug 2 19:24

Piper Sandler Gives a Hold Rating to Ardelyx (ARDX)

TipRanksAug 2 19:07

Piper Sandler Downgrades Ardelyx(ARDX.US) to Hold Rating, Cuts Target Price to $7

Futu NewsJul 23 19:38

Piper Sandler Sticks to Their Hold Rating for Ardelyx (ARDX)

TipRanksJul 23 18:47

HC Wainwright & Co. Reiterates Buy on Ardelyx, Maintains $10 Price Target

BenzingaJul 19 03:03

Ardelyx Analyst Ratings

BenzingaJul 18 21:44

Wedbush Sticks to Its Buy Rating for Ardelyx (ARDX)

TipRanksJul 18 20:50

Ardelyx's Strategic Response to Regulatory Challenges: A High-Risk Buy Rating With Potential for Substantial Return

TipRanksJul 18 08:43